Text Size

Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea

This study has been completed.
Sponsor:
Information provided by:
Bispebjerg Hospital
ClinicalTrials.gov Identifier:
NCT00483145
First received: June 4, 2007
Last updated: June 2, 2008
Last verified: June 2008
History of Changes
  Purpose

To evaluate efficacy and adverse effect from long-pulsed dye laser versus long-pulsed dye laser-mediated photodynamic therapy for acne vulgaris and rosacea.


Condition Intervention
Acne Vulgaris and Rosacea
 Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate)
Device: Long-pulsed dye laser
Device: Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single Blind
Official Title: Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea

Resource links provided by NLM:

MedlinePlus related topics: Acne Rosacea
U.S. FDA Resources

Further study details as provided by Bispebjerg Hospital:

Study Start Date: November 2006
Study Completion Date: November 2007
Arms Assigned Interventions
Active Comparator: 1
Long-pulsed dye laser (Candela)
 Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate) Device: Long-pulsed dye laser
Active Comparator: 2
Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)
 Device: Long-pulsed dye laser (Candela) and PDT (methylaminolevulinate) Device: Long-pulsed dye laser assisted fotodynamic therapy (methylaminolevulinate)

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Inflammatory acne and rosacea
  • Skin types I-IV

Exclusion Criteria:

  • Patients younger than 18 years
  • Skin types V and VI
  • Topical and systemic conventional acne treatments
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00483145

Locations
Denmark
Bispebjerg Hospital
Copenhagen NV, Denmark, 2400
Sponsors and Collaborators
Bispebjerg Hospital
Investigators
Principal Investigator: Merete Hædersdal Bispebjerg Hospital
  More Information

No publications provided

Responsible Party: Merete Hædersdal, Bispebjerg Hospital
ClinicalTrials.gov Identifier: NCT00483145     History of Changes
Other Study ID Numbers: KF-01-328309
Study First Received: June 4, 2007
Last Updated: June 2, 2008
Health Authority: Denmark: The Ministry of the Interior and Health

Additional relevant MeSH terms:
Acne Vulgaris
Rosacea
Acneiform Eruptions
Skin Diseases
Facial Dermatoses
Sebaceous Gland Diseases
Methyl 5-aminolevulinate
 Aminolevulinic Acid
Photosensitizing Agents
Radiation-Sensitizing Agents
Physiological Effects of Drugs
Pharmacologic Actions
Dermatologic Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on May 21, 2013